Clinical Trials Directory

Trials / Completed

CompletedNCT00383396

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
—
Sponsor
Innovative Medical · Industry
Sex
All
Age
—
Healthy volunteers
—

Summary

To Determine if topical cyclosporine 0.05% BID prevents recurrent inflammation and improves comfort in eyes with pterygia.

Conditions

Interventions

TypeNameDescription
DRUGTopical Cyclosporine

Timeline

First posted
2006-10-03
Last updated
2007-02-13

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00383396. Inclusion in this directory is not an endorsement.

Efficacy of Topical Cyclosporine 0.05% in the Prevention of Ocular Surface Inflammation Secondary to Pterygia (NCT00383396) · Clinical Trials Directory